The 2008 EORTC/MSG consensus definitions: What’s new? What’s next? Nikolaos G. AlmyroudisBrahm H. Segal OriginalPaper 10 November 2009 Pages: 195 - 200
Galactomannan detection in nonserum specimens: Where do we stand? Greet De VliegerKatrien LagrouWouter Meersseman OriginalPaper 10 November 2009 Pages: 201 - 206
Polymerase chain reaction diagnosis of fungal disease: Finally coming of age P. Lewis WhiteMichael D. PerryRosemary A. Barnes OriginalPaper 10 November 2009 Pages: 207 - 215
Diagnosis of aspergillosis: Role of proteomics Leonardo PotenzaPatrizia BarozziMario Luppi OriginalPaper 10 November 2009 Pages: 216 - 222
New developments in the treatment of zygomycosis George L. PetrikkosAnna Skiada OriginalPaper 10 November 2009 Pages: 223 - 228
Treatment of breakthrough fungal infections: Is there one best drug strategy? Michael D. NailorPranatharthi H. Chandrasekar OriginalPaper 10 November 2009 Pages: 229 - 235
Azole resistance in aspergillosis: The next threat? Cornelia Lass-Flörl OriginalPaper 10 November 2009 Pages: 236 - 242
Immunomodulating effects of antifungal therapy Konstantinos LeventakosRonen Ben-AmiDimitrios P. Kontoyiannis OriginalPaper 10 November 2009 Pages: 243 - 250